Drug Development Organization
The drug development organization dedicated to preclinical and clinical drug research, specializing in precision medicine using unique biomarker technologies.
The drug development organization dedicated to preclinical and clinical drug research, specializing in precision medicine using unique biomarker technologies.
As a privately owned specialized company, we are able to make decisions swiftly, leverage cross-functional synergies and quickly adapt the organization to accommodate clients’ current and future needs.
Nordic Bioscience has acquired extensive experience in rheumatology and fibrosis based on more than 25 years of experience with biomarker development and clinical trials.
The collagen and extracellular matrix specialist
The OA CRO
Nordic Bioscience is dedicated to preclinical and clinical drug development, specializing in precision medicine using unique biomarker technologies. Welcome to the Biomarker Powerhouse!
Having worked 25+ years in biomarker development and clinical trials, Nordic Bioscience has acquired extensive expertise in rheumatology, fibrosis and oncology in particular.
We have more than 50 articles published each year in well respected, peer-reviewed journals. This year we exceeded 400 publications in total
We tailor our unique solutions to our clients’ needs.
As a privately owned specialized company, we are able to make decisions swiftly, leverage cross-functional synergies and quickly adapt the organization to accommodate clients’ current and future needs.